Triple

T4755195
Position Surface form Disambiguated ID Type / Status
Subject Federal Institute for Drugs and Medical Devices E105569 entity
Predicate nativeName P15 FINISHED
Object Bundesinstitut für Arzneimittel und Medizinprodukte E105569 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Bundesinstitut für Arzneimittel und Medizinprodukte | Statement: [Federal Institute for Drugs and Medical Devices, nativeName, Bundesinstitut für Arzneimittel und Medizinprodukte]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Bundesinstitut für Arzneimittel und Medizinprodukte
Context triple: [Federal Institute for Drugs and Medical Devices, nativeName, Bundesinstitut für Arzneimittel und Medizinprodukte]
  • A. Federal Institute for Drugs and Medical Devices chosen
    The Federal Institute for Drugs and Medical Devices is Germany’s central regulatory authority responsible for the authorization, safety monitoring, and risk assessment of pharmaceuticals and medical devices.
  • B. Paul Ehrlich Institute
    The Paul Ehrlich Institute is Germany’s federal agency and research institution responsible for the evaluation, authorization, and monitoring of vaccines and biomedicines.
  • C. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • D. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • E. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69bd43f07fa48190954317d01600994a completed March 20, 2026, 12:56 p.m.
NER Named-entity recognition batch_69bd64e882b08190b100582e6d2e0334 completed March 20, 2026, 3:16 p.m.
NED1 Entity disambiguation (via context triple) batch_69be3a6c7f3c8190b97705bd859c82e8 completed March 21, 2026, 6:27 a.m.
Created at: March 20, 2026, 1:20 p.m.